Catalyst Pharmaceuticals Inc’s recently made public that its Chairman of Board of Directors MCENANY PATRICK J unloaded Company’s shares for reported $2.13 million on Nov 13 ’24. In the deal valued at $22.98 per share,92,500 shares were sold. As a result of this transaction, MCENANY PATRICK J now holds 4,478,169 shares worth roughly $92.25 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MCENANY PATRICK J sold 44,655 shares, generating $971,336 in total proceeds. Upon selling the shares at $21.75, the Chairman of Board of Directors now owns 4,478,169 shares.
Before that, MCENANY PATRICK J bought 44,655 shares. Catalyst Pharmaceuticals Inc shares valued at $971,327 were divested by the Director at a price of $21.75 per share.
Citigroup initiated its Catalyst Pharmaceuticals Inc [CPRX] rating to a Buy in a research note published on March 14, 2024; the price target was $27. A number of analysts have revised their coverage, including BofA Securities’s analysts, who began to cover the stock in early March with a ‘”a Buy”‘ rating. Oppenheimer began covering CPRX with “an Outperform” recommendation on December 21, 2023. ROTH Capital revised its rating on August 24, 2022. It rated CPRX as “a Neutral” which previously was an “a Buy”.
Price Performance Review of CPRX
On Friday, Catalyst Pharmaceuticals Inc [NASDAQ:CPRX] saw its stock fall -5.03% to $20.60. Over the last five days, the stock has lost -13.92%. Catalyst Pharmaceuticals Inc shares have risen nearly 22.55% since the year began. Nevertheless, the stocks have risen 50.92% over the past one year. While a 52-week high of $24.27 was reached on 11/08/24, a 52-week low of $13.00 was recorded on 02/08/24. SMA at 50 days reached $20.99, while 200 days put it at $17.42.
Levels Of Support And Resistance For CPRX Stock
The 24-hour chart illustrates a support level at 20.15, which if violated will result in even more drops to 19.70. On the upside, there is a resistance level at 21.34. A further resistance level may holdings at 22.08. The Relative Strength Index (RSI) on the 14-day chart is 39.71, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.60, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 95.82%. Stochastics %K at 24.09% indicates the stock is a holding.
How much short interest is there in Catalyst Pharmaceuticals Inc?
A steep rise in short interest was recorded in Catalyst Pharmaceuticals Inc stocks on 2024-10-31, growing by 0.26 million shares to a total of 6.01 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 5.75 million shares. There was a rise of 4.38%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on September 21, 2018 when Cantor Fitzgerald began covering the stock and recommended ‘”an Overweight”‘ rating .
